Insights

Early Cancer Detection Micronoma offers a microbiome-driven liquid biopsy platform aimed at early cancer detection, presenting a potential sales path to hospitals, oncology clinics, and research centers seeking innovative screening tools with clinical-grade accuracy.

Clinical Partnerships Recent collaboration with New York University on NSCLC biomarkers funded by the National Cancer Institute highlights a proven interest from major research institutions, suggesting opportunities to expand academic and clinical trial partnerships.

Regulatory Milestones FDA Breakthrough Device Designation for the OncobiotaLUNG assay signals heightened visibility and credibility, enabling conversations with health systems and payer groups about faster adoption and potential reimbursement pathways.

Strategic Hiring Key hires in corporate communications, quality, CLS operations, and business development indicate a ramp in commercialization and regulatory readiness, which can be leveraged to propose joint projects, pilots, and market access initiatives.

Funding & Growth With under one million in revenue but $18 million in funding and a focused biotechnologies platform, there is an opportunity to position Micronoma for contract research, licensing, and co-development deals with larger biotech and diagnostic firms.

Similar companies to Micronoma

Micronoma Tech Stack

Micronoma uses 8 technology products and services including WordPress, Shopify, jQuery, and more. Explore Micronoma's tech stack below.

  • Content Management System
  • E-commerce
  • jQuery
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Marketing Automation
  • HSTS
    Security
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers

Media & News

Micronoma's Email Address Formats

Micronoma uses at least 2 email formats:
Micronoma Email FormatsExamplePercentage
First.Last@micronoma.comJohn.Doe@micronoma.com
93%
FirstLast@micronoma.comJohnDoe@micronoma.com
7%

Frequently Asked Questions

What is Micronoma's official website and social media links?

Minus sign iconPlus sign icon
Micronoma's official website is micronoma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Micronoma generate?

Minus sign iconPlus sign icon
As of November 2026, Micronoma's annual revenue is estimated to be <$1M.

What is Micronoma's SIC code and NAICS code?

Minus sign iconPlus sign icon
Micronoma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Micronoma have currently?

Minus sign iconPlus sign icon
As of November 2026, Micronoma has approximately 2 employees across 1 continents, including North America. Key team members include President And Ceo: S. M. Explore Micronoma's employee directory with LeadIQ.

What industry does Micronoma belong to?

Minus sign iconPlus sign icon
Micronoma operates in the Biotechnology Research industry.

What technology does Micronoma use?

Minus sign iconPlus sign icon
Micronoma's tech stack includes WordPress, Shopify, jQuery, Swiper, Klaviyo, HSTS, Google Analytics and Apache.

What is Micronoma's email format?

Minus sign iconPlus sign icon
Micronoma's email format typically follows the pattern of First.Last@micronoma.com. Find more Micronoma email formats with LeadIQ.

How much funding has Micronoma raised to date?

Minus sign iconPlus sign icon
As of November 2026, Micronoma has raised $18M in funding. The last funding round occurred on Mar 31, 2022.

When was Micronoma founded?

Minus sign iconPlus sign icon
Micronoma was founded in 2019.
Micronoma logo

Micronoma

Biotechnology ResearchCalifornia, United States2-10 Employees

Micronoma is a San Diego–based biotechnology research company focused on early cancer detection through liquid biopsy techniques that interrogate microbial signals with clinical-grade accuracy. Founded in 2019, the company aims to identify microbial biomarkers capable of predicting cancer and potential recurrence, seeking to improve the diagnostic process for individuals facing cancer. Its work positions it at the intersection of microbiome science and oncology, addressing the need for earlier, noninvasive cancer detection. The organization has pursued partnerships and leadership appointments to advance its development, including a collaboration with New York University on a National Cancer Institute–funded project related to non-small cell lung cancer, and the addition of leadership roles in corporate communications, quality, and business development. Micronoma’s activities are anchored in its core platform for microbiome-driven, liquid biopsy-based cancer detection.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $18M

    Micronoma has raised a total of $18M of funding over 3 rounds. Their latest funding round was raised on Mar 31, 2022 as a Convertible Note.

  • <$1M

    Micronoma's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.